online pharmacy, prescription drugs online



Drugs online research references











  • Withdrawal of beta-blocking drugs.
  • Beta-adrenoceptor blocking drugs and calcium transport in isolated rat mast cells.
  • Use of nifedipine as the drug of third choice in management of hypertension.
  • Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells.
  • Effects of antiglaucoma drugs on 32Porthophosphate incorporation into phospholipids of cat iris and ciliary process.
  • The effect of adrenergic agonists and antagonists on cysteine-proteinase inhibitor (cystatin) in rat saliva.
  • The effect of adrenergic agonists and antagonists on the expression of proteins in rat submandibular and parotid glands.
  • Angina pectoris caused by dynamic coronary obstruction and beta-blockers
  • Eclampsia.
  • The electrophysiologic effect of atenolol and nitrendipine on normal and ischemic rabbit myocardium in situ. I. Effects on transmembrane potential
  • Beta-adrenergic receptor blockade in the management of pregnant women with mitral stenosis.
  • Mechanism of beneficial effect of beta-adrenergic blockade on exercise-induced myocardial ischemia in conscious dogs.
  • Haemodynamic long-term effects of beta-receptor-blocking agents in hypertension: a comparison between alprenolol, atenolol, metoprolol and timolol.
  • Haemodynamic long-term effects of metoprolol at rest and during exercise in essential hypertension.
  • Analysis of the adverse effects of drugs at the cellular and subcellular levels
  • Stimulant and depressant effects of beta-adrenoceptor blocking agents on isolated heart muscle. A positive inotropic effect not mediated through andrenoceptors.
  • Analysis of the combined effect of 1-menthol and ethanol as skin permeation enhancers based on a two-layer skin model.
  • Circulatory and metabolic effects of acute beta 1-blockade in severe pre-eclampsia.
  • Chronotropic and inotropic effects of kampo extracts in the canine isolated, blood-perfused heart preparations.
  • Direct negative inotropic effect of cocaine in rat ventricle strip
  • Effect of nisoldipine on electrophysiological parameters in patients pretreated with beta-blockers.
  • Permeability of the blood-brain barrier for atenolol studied by positron emission tomography.
  • Norepinephrine-induced beta 1-adrenergic peripheral vasodilation in conscious dogs.
  • Atenolol inhibits the elimination of disopyramide.
  • Effect of nifedipine and enalapril on cardiac autonomic activity in elderly hypertensive patients
  • Isoproterenol-induced enhancement of myocardial glucose-6-phosphate dehydrogenase.
  • Psychosocial stress causes endothelial injury in cynomolgus monkeys via beta1-adrenoceptor activation.
  • Differential cardiovascular effects of propranolol, atenolol, and pindolol measured by impedance cardiography.
  • Comparison of the effect of eleven beta-adrenoceptor blocking drugs in perturbing lipid membrane: an ESR spectroscopy study.
  • Vasoactive agonists prevent erythrocyte extravasation in thrombocytopenic hamsters.
  • Atenolol vs. propranolol in essential tremor. A controlled, quantitative study.
  • Are there alpha-adrenoceptors in the young chick atria?
  • Effect of short-term beta blockade on serum lipid levels and on the interaction of LDL with human arterial proteoglycans.
  • The role of beta- and alpha-adrenoceptors in the regulation of the stages of the sleep-waking cycle in the cat.
  • Hypertension in pregnancy: evaluation of two beta blockers atenolol and labetalol.
  • Atenolol therapy for exercise-induced hypertension after aortic coarctation repair.
  • Attenuation of the rise in extracellular potassium concentration during myocardial ischaemia by d.l-sotalol and d-sotalol.
  • Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
  • Complaints of cold extremities among patients on antihypertensive treatment.
  • Influence of morphometric factors on quantitation of paracellular permeability of intestinal epithelia in vitro.
  • Managing hypertension in family practice: a nationwide collaborative study of the use of four antihypertensives in the treatment of mild-to-moderate hypertension. A report from CEN. Clinical Experience Network.
  • Postoperative atrial fibrillation in myocardial revascularization
  • A new model of ventricular fibrillation induced by isoprenaline and catechol-O-methyl transferase inhibitor at a high perfusion temperature in isolated rat hearts.
  • Effect of beta-adrenergic blockers on isolated coronary arterial strip and tracheal smooth muscle of pig.
  • Regional myocardial blood flow and function in experimental myocardial ischemia.
  • Tissue atenolol levels following chronic beta-adrenoceptor blockade using oral atenolol in dogs.
  • Isoproterenol, DBcAMP, and forskolin inhibit cardiac sodium current.
  • Involvement of amygdalar alpha adrenoceptors in hypothalamo-pituitary-adrenocortical responses.
  • QT intervals at heart rates from 50 to 120 beats per minute during 24-hour electrocardiographic recordings in 100 healthy men. Effects of atenolol.
  • Effect of catecholamine on aldosterone release in isolated rat glomerulosa cell suspensions.
  • Abrupt and gradual change from clonidine to beta blockers in hypertension.
  • Dibutyryl-cAMP increases functions of 5-hydroxytryptamine2 receptors, but not of beta 2-adrenergic receptors, in a clonal cell line of rat neurotumor RT4.
  • Running performance as a function of the dose-response relationship to beta-adrenoceptor blockade.
  • Dorsomedial hypothalamic GABA regulates anxiety in the social interaction test.
  • Effects of beta-adrenergic blockers with different ancillary properties on lipid peroxidation in hyperthyroid rat cardiac muscle.
  • Modulation of interferon gamma induced increases in cathepsin B in THP-1 cells by adrenergic agonists and antagonists.
  • The influence of gastrointestinal transit on drug absorption in healthy volunteers.
  • Adrenergic control of cAMP generation in rat inner medullary collecting tubule cells.
  • Involvement of the adrenal glands in the hypotensive response to bromocriptine in spontaneously hypertensive rats.
  • Adrenergic regulation of glycogenolysis in isolated guinea-pig hepatocytes: evidence that beta 2-receptors mediate catecholamine stimulation of glycogenolysis.
  • Enzyme activity of cardiac glycogen metabolism: study of an in situ hypoxia protocol in the rat
  • Partial agonists at guinea-pig atrial beta-adrenoceptors display relaxation responses in the guinea-pig ileum independent of beta-adrenoceptor stimulation.
  • Effects of beta 1- and beta 1 + beta 2-antagonists on training-induced myocardial hypertrophy and enzyme adaptation.
  • Fetal and uteroplacental haemodynamics during short-term atenolol treatment of hypertension in pregnancy.
  • Cost considerations in headache treatment. Part 1: Prophylactic migraine treatment.
  • Effects of beta-adrenergic blockade on left ventricular relaxation and filling dynamics in coronary artery disease: a pulsed Doppler echocardiographic study.
  • Cardiomyopathic hamster hearts: long-term effects of drugs on catecholamine contents and binding characteristics of alpha 1- and beta 1-adrenergic receptors.
  • Short-term systemic hemodynamic adaptation to beta-adrenergic inhibition with atenolol in hypertensive patients.
  • Jejunal permeability and hepatic extraction of fluvastatin in humans.
  • Beta-adrenoceptor heterogeneity in guinea-pig airways: comparison of functional and receptor labelling studies.
  • Stereoselective high-performance liquid chromatographic assay for the determination of sotalol enantiomers in biological fluids.
  • Influence of thyroid hormones and catecholamines on myosin of swim-exercised rats.
  • Design of polyvinyl alcohol hydrogel as a controlled-release vehicle for rectal administration of dl-propranolol-HCl and atenolol.
  • Acute effect of atenolol on hemodynamic, plasma renin activity and plasma aldosterone concentration in the once daily oral administration.
  • Action of ciguatoxin on human atrial trabeculae.
  • Adrenergic receptors in human liver plasma membranes: predominance of beta 2- and alpha 1-receptor subtypes.
  • Regional myocardial tissue blood flow during sequential beta 1- and beta 2-adrenergic blockade in cat hearts with acute ischaemia.
  • Norepinephrine regulates human chorionic gonadotrophin production by first trimester trophoblast tissue in vitro.
  • Selectivity of bevantolol hydrochloride, a beta 1-adrenoceptor antagonist, in asthmatic patients.
  • The clinical profile of hypertensive patients can predict the need for combining a second or third drug with atenolol in the initial treatment of light and moderate essential arterial hypertension
  • Platelet adhesion in hyperlipidemic and hypertensive patients.
  • Isoproterenol causes hyperpolarization through opening of ATP-sensitive potassium channels in vascular smooth muscle of the canine saphenous vein.
  • Demonstration of both beta 1- and beta 2-adrenoceptors mediating relaxation of isolated ring preparations of rat pulmonary artery.
  • Comparison of the cardiac and hemodynamic effects of lisinopril and atenolol in patients with hypertension: therapeutic implications.
  • Adenosine formation during hypoxia in isolated hearts: effect of adrenergic blockade.
  • Is neurally mediated hypotension an unrecognised cause of chronic fatigue?
  • The influence of atropine and atenolol on the cardiac haemodynamic effects of NG-nitro-L-arginine methyl ester in conscious, Long Evans rats.
  • Effects of beta-adrenergic blockers on drug-induced tremors.
  • Effect of fenoterol on immunological release of leukotrienes and histamine from human lung in vitro: selective antagonism by beta-adrenoceptor antagonists.
  • Parabrachial lesions increase plasma norepinephrine concentration, plasma renin activity and enhance baroreflex sensitivity in the conscious rat.
  • Arterial contractions induced by cumulative addition of calcium in hypertensive and normotensive rats: influence of endothelium.
  • Limitation of myocardial infarct size by atenolol, nadolol and propranolol in dogs.
  • Benazepril: a new ACE inhibitor.
  • Lipophilic beta-blockers inhibit rat skeletal muscle mitochondrial respiration.
  • Intramural nerve-mediated inotropic responses of left atria of rats and guinea pigs: demonstration of alpha adrenergic and nonadrenergic noncholinergic responses in guinea pigs.
  • Thaliporphine, a positive inotropic agent with a negative chronotropic action.
  • Pharmacological mechanisms in the cardiovascular effects of methamphetamine in conscious squirrel monkeys.
  • Interactions of carteolol and other beta-adrenoceptor blocking agents with serotonin receptor subtypes.
  • Inhibition of purified bovine milk lipoprotein lipase by propranolol and other beta-adrenergic blockers in vitro.
  • Involvement of epinephrine in the presynaptic beta adrenoceptor mechanism of norepinephrine release from rat hypothalamic slices.
  • Treatment of hypertension in pregnant women with beta-blockers. 60 cases
  • Beta-adrenoceptor mediated inhibition of behavioral action of desipramine and of central noradrenergic activity in forced swimming rats.
  • Beta adrenoceptor blockade in rabbit inhibits the renin-releasing effect of AT1 receptor antagonist losartan.
  • Beta-adrenoceptor-mediated inhibition of alpha 1-adrenoceptor-mediated and field stimulation-induced contractile responses in the prostate of the guinea pig.
  • Attenuation of insulin-induced drinking by beta-adrenoceptor antagonists.
  • Nifedipine/atenolol interactions in gastrointestinal absorption and biotransformation.
  • Lack of a pharmacokinetic interaction between nifedipine and the beta-adrenoceptor blockers metoprolol and atenolol.
  • Possible activation of intracellular beta-adrenoceptors by extraneuronally accumulated isoprenaline in perfused rat heart.
  • Comparative effect of intravenous administration of atenolol and practolol on resting and exercise-evoked increase in heart rate and cardiac work load in normal human subjects.
  • A comparison of guanfacine, bunazosin, atenolol and nadolol on blood pressure and plasma noradrenaline responses to cold pressor testing.
  • (+/-)-1-2-(3,4-Dimethoxphenyl)ethylamino-3-(3-methylphenoxy)-2- propanol hydrochloride (bevantolol, NC-1400) as a beta 1-selective adrenoceptor blocker with alpha 1-adrenoceptor blocking activity.
  • Conjunctival penetration of insulin and peptide drugs in the albino rabbit.
  • Beta adrenergic antagonists inhibit serotonin uptake by pulmonary vascular cells in culture.
  • On the relationship between incorporation of 32P into phospholipids and binding of beta-adrenoceptor blocking drugs to isolated mast cells.
  • Regulation of liver lipase. II. Involvement of the alpha 1-receptor.
  • Hypoxic cardiac hypertrophy is not inhibited by cardioselective or non-selective beta-adrenoceptor antagonists.
  • Beta-adrenoceptor density and relative number of beta-adrenoceptor subtypes in biopsies from human right atrial, left ventricular, and right ventricular myocard.
  • Beta-blockade in the ischemic reperfused working rabbit heart: dissociation of beta-adrenergic blocking and protective effects.
  • Effects of chronic isoproterenol administration on beta 1-adrenoceptors and growth of pancreas of young and adult rats.
  • Prevention and reversal of isolation-induced systolic arterial hypertension in rats by treatment with beta-adrenoceptor antagonists.
  • Central nervous system kinetics of atenolol and metoprolol in the dog during long term treatment.
  • Effect of beta-adrenoceptor blocking drugs on 32P incorporation into and arachidonic acid liberation from phospholipids in stimulated rat mast cells.
  • L-3,4-(3-3,4-dimethoxyphenethylamino-2-hydroxypropoxy)-phenyl- crotonic acid nitrile.HCl (Hoe 224), a beta-blocking agent with high beta 1-selectivity.
  • Effects of regression of left ventricular hypertrophy following atenolol or bunazosin therapy on ischemic cardiac function and myocardial metabolism in spontaneously hypertensive rats.
  • Changes in blood pressure and thermographic values resulting from use of a beta-blocker plus diuretic and of an alpha-beta-blocker plus diuretic.
  • Comparison of effects on lipid metabolism of antihypertensive drugs with alpha- and beta-adrenergic antagonist properties.
  • Characteristics of the lipolytic beta-adrenergic receptors in hamster adipocytes.
  • Improved high-performance liquid chromatography assay for atenolol in plasma and urine using fluorescence detection.
  • Autoradiographic localization of beta-adrenoceptors in pig lung using 125I-iodocyanopindolol.
  • Renin release induced by losartan (DuP 753), an angiotensin II receptor antagonist.
  • Multiple heteroreceptors on limbic thalamic axons: M2 acetylcholine, serotonin1B, beta 2-adrenoceptors, mu-opioid, and neurotensin.
  • Antinuclear antibodies and lupus induced during treatment of arterial hypertension. Role of beta-blockers and alpha-methyldopa
  • Beta-adrenoreceptors in rat brown adipose tissue: proportions of beta 1- and beta 2-subtypes.
  • Time course of reduction in left ventricular mass during long-term antihypertensive therapy.
  • Effects of L-propionylcarnitine on electrical and mechanical alterations induced by amphiphilic lipids in isolated guinea pig ventricular muscle.
  • Inhibition of purified lysosomal phospholipase A1 by beta-adrenoceptor blockers.
  • Exercise haemodynamics and maximal exercise capacity during beta-adrenoceptor blockade in normotensive and hypertensive subjects.
  • Investigation of the mechanism of propranolol-induced bronchoconstriction.
  • Alpha 1-adrenoceptor mediation of urinary bicarbonate excretion.
  • The beta-adrenoreceptors mediating uterine relaxation throughout the oestrous cycle of the rat are predominantly of the beta 2-subtype.
  • Extent and pharmacokinetic mechanisms of oral atenolol-verapamil interaction in man.
  • Serotonin 5-HT1A receptors mediate inhibition of tyrosine hydroxylation in rat striatum.
  • The haemodynamic and metabolic effects of tolmesoxide with special reference to impaired myocardial function.
  • Apparent affinity values of beta-adrenergic blockers in a tissue with a mixture of beta-adrenergic receptor subtypes.
  • Aldosterone response to metoclopramide is mediated through the autonomic nervous system in man.
  • Atenolol, but not mexiletine, protects against stimulus-induced ventricular tachycardia in a chronic canine model.
  • Participation of alpha 1- and beta 1-adrenoceptors in norepinephrine-induced contraction and relaxation of isolated equine coronary artery in vitro.
  • Beta-blockers inhibit the modification of low-density lipoproteins by sodium hypochlorite in vitro.
  • Effects of ACE inhibition and beta-blockade on collagen remodelling in the heart of Bio 14.6 hamsters.
  • Beta-blockers: propranolol, metoprolol, atenolol, pindolol, alprenolol and timolol, manifest atherogenicity on in vitro, ex vivo and in vivo models. Elimination of propranolol atherogenic effects by papaverine.
  • Role of ganglionic M-1 and M-2 receptors in the neuronal control of the cardiovascular system of the normotensive rat as determined with pilocarpine.
  • GABAergic and glutaminergic modulation of centrally evoked arrhythmias in rats.
  • Subclassification of muscarinic receptors in the heart, urinary bladder and sympathetic ganglia in the pithed rat. Selectivity of some classical agonists.
  • Effects of the myocardial-selective alpha 1-adrenoceptor antagonist UK-52046 and atenolol, alone and in combination, on experimental cardiac arrhythmias in dogs.
  • Failure of isoprenaline and beta-receptor blocking drugs to modify depressor response and bradycardia induced by electrical stimulation of the anterior hypothalamus of cats.
  • Inhibition of aortic aneurysm development in blotchy mice by beta adrenergic blockade independent of altered lysyl oxidase activity.
  • Release of atrial natriuretic peptide by atrial distension.
  • Cardiovascular and phrenic nerve responses to stimulation of the amygdala central nucleus in the anaesthetized rabbit.
  • Epinephrine facilitates neurogenic responses in isolated segments of dog mesenteric arteries.
  • The effects of combined angiotensin converting enzyme inhibition and beta-adrenoceptor blockade on plasma renin activity in anaesthetized dogs.
  • Felodipine compared to nifedipine as "third-line drug" in resistant hypertension.
  • Study of the influence of nifedipine on the pharmacokinetics and pharmacodynamics of propranolol, metoprolol and atenolol.
  • Renoprotective effect of nisoldipine in rats with severe hypertension.
  • Effects of selective and non-selective beta-adrenergic blockade on coronary dynamics in man assessed by rapid atrial pacing.
  • Importance of cardiac, but not vascular, hypertrophy in the cardiac baroreflex deficit in spontaneously hypertensive and stroke-prone rats.
  • Effects of full and partial beta-adrenergic agonists and antagonists on human lung adenylate cyclase.
  • Local modulation of noradrenaline release in vivo: presynaptic beta 2-adrenoceptors and endogenous adrenaline.
  • Role of angiotensin-converting enzyme, adrenergic receptors, and blood pressure in cardiac gene expression of spontaneously hypertensive rats during development.
  • Blood pressure and plasma noradrenaline during single high-dose beta adrenoceptor blockade.
  • Stimulation of phospholipid N-methylation by isoproterenol in rat hearts.
  • Atenolol elimination in the neonate.
  • Formulation influence on ocular and systemic absorption of topically applied atenolol in the pigmented rabbit.
  • SK&F 87516, a close analog of fenoldopam, is a partial agonist at dopamine-1 and alpha-2 receptors and produces stimulation of 5-hydroxytryptamine-2 receptors in the cardiovascular system of the rat.
  • Efficacy and renal effects of enalapril therapy for hypertensive patients with chronic renal insufficiency.
  • Circadian phase dependency of the effects of different beta-receptor blocking drugs on motor activity of rats. Importance of drug lipophilicity.
  • The cardiovascular effects of centrally administered 5-hydroxytryptamine in the conscious normotensive and hypertensive rat.
  • Anti-arrhythmic efficacy of beta-adrenergic blockade during acute ischemia in myocardium with scar.
  • Pharmacological properties of presynaptic beta-adrenoceptors in guinea-pig pulmonary arteries.
  • Comparison of the profiles of agonists as stimulants of the beta 3-adrenoceptor in vitro with their gastroprotective effects in the conscious rat.
  • Simultaneous determination of atenolol and chlorthalidone in plasma by high-performance liquid chromatography. Application to pharmacokinetic studies in man.
  • Simultaneous determination of the beta-blocker atenolol and several complementary antihypertensive agents in pharmaceutical formulations and urine by capillary zone electrophoresis.
  • Influence of isoproterenol on plasma immunoreactive atrial natriuretic peptide and plasma vasopressin in the anesthetized rabbit.
  • Activation of carbonic anhydrase by beta-adrenergic agonists and inhibition by beta-adrenergic blockers.
  • Beta 2-adrenergic receptors on eosinophils. Binding and functional studies.
  • Functional characterization of beta-adrenoceptor subtypes in rabbit right atria.
  • Separation and quantitation of (R)- and (S)-atenolol in human plasma and urine using an alpha 1-AGP column.
  • Effects of beta blockaders on ventilatory function in chronic bronchitis
  • Long-term beta 1-adrenergic blockade restores adrenomedullary activity in primary hypertension.
  • Acute and long-term effects of nitrendipine on resting and exercise hemodynamics in essential hypertension.
  • Systemic and ocular effects of alpha 2-adrenergic stimulating and beta 2-blocking agents.
  • Propranolol reduces anoxia/reoxygenation-mediated injury of adult myocytes through an anti-radical mechanism.
  • beta-Adrenergic stimulation of skeletal muscle metabolism in relation to weight reduction in obese men.
  • Relationship between amount of beta-blockers permeating through the stratum corneum and skin irritation after application of beta-blocker adhesive patches to guinea pig skin.
  • Chronotropic effects of optical isomers of ephedrine and methylephedrine in the isolated rat right atria and in vitro assessment of direct and indirect actions on beta 1-adrenoceptors.
  • Passive diffusion of weak organic electrolytes across Caco-2 cell monolayers: uncoupling the contributions of hydrodynamic, transcellular, and paracellular barriers.
  • Beta 1- and beta 2-adrenoceptor subtypes in canine intrathoracic efferent sympathetic nervous system regulating the heart.
  • Substantial cardiac parasympathetic activity exists during heavy dynamic exercise in dogs.
  • Neurohumoral changes in patients with heart failure treated chronically with beta-blockers
  • Modulation of the vagal bradycardia evoked by stimulation of upper airway receptors by central 5-HT1 receptors in anaesthetized rabbits.
  • Improvement of pentobarbital-induced heart failure by MCI-154, a novel and potent cardiotonic agent, in the dog heart-lung preparation.
  • Exercise and cardiac performance capacity in rats with partial sympathectomy.
  • Alterations in lipid peroxidation of thrombin-stimulated rat platelets treated with beta-adrenoceptor blocking drugs.
  • Pharmacokinetic and pharmacodynamic properties of atenolol in acute myocardial infarction.
  • Exercise and the pharmacokinetics of propranolol, verapamil and atenolol.
  • Hemodynamic and pharmacokinetic study of propranolol and atenolol in cirrhosis patients.
  • A comparison of the pharmacokinetics of atenolol, metoprolol, oxprenolol and propranolol in elderly hypertensive and young healthy subjects.
  • Pharmacokinetics and pharmacodynamics of atenolol in children.
  • Agreement between the pharmacy medication history and patient interview for cardiovascular drugs: the Rotterdam elderly study.
  • Haemodynamic effects and pharmacokinetics of felodipine at rest and during exercise in hypertensive patients treated with metoprolol or atenolol.
  • Transplacental passage and breast milk concentrations of hydralazine.
  • Xerostomia: prevalence and pharmacotherapy. With special reference to beta-adrenoceptor antagonists.
  • Differential effect of physical exercise routines on ventricular myosin and peripheral catecholamine stores in normotensive and spontaneously hypertensive rats.
  • Sympathetic responsiveness and antihypertensive effect of beta-receptor blockade in essential hypertension.
  • Nocturnal oscillations of plasma aldosterone in relation to sleep stages.
  • Effects of some drugs on plasma uric acid in rats--actions of catecholamines and beta-blocking agents
  • Stroke volume decline during prolonged exercise is influenced by the increase in heart rate.
  • Analytical methodology for enantiomers of salbutamol in human urine for application in doping control.
  • Bradykinin B1 and B2 receptors, tumour necrosis factor alpha and inflammatory hyperalgesia.
  • Inhibition of lipid peroxidation by pindolol.
  • Thermogenic effects of sibutramine and its metabolites.
  • Lack of effect of chronic calcium antagonist treatment on beta 1- and beta 2-adrenoceptors in right atria from patients with or without heart failure.
  • Affinities for alpha- and beta-adrenoceptor subtypes of YM-09538, a new combined alpha- and beta-adrenoceptor antagonist, by radioligand binding assay.
  • Functional characterization of beta-adrenoceptors mediating relaxation in sheep gallbladder.
  • Alterations in cardiac beta-adrenergic receptors in chagasic mice and their association with circulating beta-adrenoceptor-related autoantibodies.
  • Analysis of urine samples containing cardiovascular drugs by micellar liquid chromatography with fluorimetric detection.
  • Atenolol depresses post-ischaemic recovery in the isolated rat heart.
  • Beta-adrenoceptors in the detrusor of guinea pig bladder.
  • Selective lysosomal uptake and accumulation of the beta-adrenergic antagonist propranolol in cultured and isolated cell systems.
  • Beta1-adrenergic receptors but not beta2-adrenergic or vasopressin receptors regulate K+ secretion in vestibular dark cells of the inner ear.
  • Possible involvement of descending serotonergic systems in antinociception by centrally administered elcatonin in mice.
  • Amiodarone protects cardiac myocytes against oxidative injury by its free radical scavenging action.
  • Role of genomic mechanisms on cAMP-dependent positive inotropism in isolated left atrium of rat.
  • The role of intracellular calcium in A-23187 stimulated and beta-adrenoceptor blocking drug treated blood platelets.
  • Heart rate surges during REM sleep are associated with theta rhythm and PGO activity in cats.
  • Selective beta1-adrenoceptor blockade enhances the activity of the stimulatory G-protein in human atrial myocardium.
  • Canine ventricular myocyte beta2-adrenoceptors are not functionally coupled to L-type calcium current.
  • Angiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo.
  • ATP as a source of interstitial adenosine in the rat heart.
  • Modeling, design, chiral aspects and role of para-substituents in aryloxypropranolamine based beta-blockers.
  • In vivo evidence that isoproterenol may increase heart rate in the rat by mechanisms in addition to activation of cardiac beta(1)- or beta(2)-adrenoceptors.
  • Pharmacological analysis of atypical beta-adrenoceptors in the guinea pig gastric fundus using the beta(3)-adrenoceptor antagonist bupranolol.
  • PF9404C, a new slow NO donor with beta receptor blocking properties.
  • Binding to serum alpha 1-acid glycoprotein and effect of beta-adrenoceptor antagonists in rats with inflammation.
  • Human ciliary process adrenergic receptor: pharmacological characterization.
  • Actions of neuropeptide Y on the rat adrenal cortex.
  • Pharmacological analysis of atypical beta-adrenoceptors in the guinea pig gastrointestinal tissue systems
  • Doping control for beta-adrenergic compounds through hair analysis.
  • The coupling of canine ventricular myocyte beta2-adrenoceptors to L-type calcium current
  • The characteristics of left ventricular remodelling in hypertensive heart patients and the possibilities for its drug correction
  • Antisense inhibition of beta(1)-adrenergic receptor mRNA in a single dose produces a profound and prolonged reduction in high blood pressure in spontaneously hypertensive rats.
  • TR146 cells grown on filters as a model of human buccal epithelium: IV. Permeability of water, mannitol, testosterone and beta-adrenoceptor antagonists. Comparison to human, monkey and porcine buccal mucosa.
  • Photodegradation studies on Atenolol by liquid chromatography.
  • The effects of ICI 118,587 and atenolol on the responses to exercise and on breathlessness in healthy subjects.
  • Carvedilol stimulates nitric oxide synthesis in rat cardiac myocytes.
  • Normothermic ischemic cardiac arrest in the isolated working rabbit heart: effects of dl-nebivolol and atenolol.
  • Effect of beta-adrenoceptor blockers on sarcoplasmic reticular function and gene expression in the ischemic-reperfused heart.
  • The Effects of Intrinsic Sympathomimetic Activity on Beta-Blocker Efficacy for Treatment of Neurocardiogenic Syncope.
  • In vitro and in vivo evaluation of the antihypertensive drug atenolol in cultured human lymphocytes: effects of long-term therapy.
  • Enantioselective analysis of (R)- and (S)-atenolol in urine samples by a high-performance liquid chromatography column-switching setup.
  • K+ secretion in strial marginal cells is stimulated via beta 1-adrenergic receptors but not via beta 2-adrenergic or vasopressin receptors.
  • Nebivolol inhibits human aortic smooth muscle cell growth: effects on cell cycle regulatory proteins.
  • Betaxolol, a beta(1)-adrenoceptor antagonist, reduces Na(+) influx into cortical synaptosomes by direct interaction with Na(+) channels: comparison with other beta-adrenoceptor antagonists.
  • Beta 2-adrenergic receptor and angiotensin II receptor modulation of sympathetic neurotransmission in human atria.
  • Expression and activity of protein kinase D/protein kinase C mu in myocardium: evidence for alpha1-adrenergic receptor- and protein kinase C-mediated regulation.
  • L-Dopa uptake and dopamine production in proximal tubular cells are regulated by beta(2)-adrenergic receptors.
  • Differences in cardioprotective efficacy of adrenergic receptor antagonists and Ca2+ channel antagonists in an animal model of dilated cardiomyopathy. Effects on gross morphology, global cardiac function, and twitch force.
  • Beta-adrenergic receptor subtypes differentially affect apoptosis in adult rat ventricular myocytes.
  • Hypertrophic effect of selective beta(1)-adrenoceptor stimulation on ventricular cardiomyocytes from adult rat.
  • Determination of the pKa values of beta-blockers by automated potentiometric titrations.
  • Pharmacotherapy in patients with ischemic heart disease and diabetes mellitus in 1998 in the Czech Republic
  • Involvement of cAMP and beta-adrenoceptors in the relaxing effect elicited by flavonoids on rat uterine smooth muscle.
  • Nebivolol induces NO-mediated relaxations of rat small mesenteric but not of large elastic arteries.
  • Controversies surrounding the treatment of the hypertensive patient with diabetes.
  • Cell-enlargement-related polypeptides are induced via beta(1)-adrenoceptors in mouse parotids.
  • Adenosine A(2a)-receptor activation increases contractility in isolated perfused hearts.
  • Enantiomeric separation and quantitative determination of atenolol in tablets by chiral high-performance liquid chromatography.
  • Effects of acute cardioselective and non-selective beta-adrenergic blockade on plasma ammonia levels in exercising dogs.
  • Imidazole receptor agonists--a new advance in the treatment of hypertension?
  • Effects of the beta 2-adrenoceptor agonist clenbuterol on tyrosine and tryptophan in plasma and brain of the rat.
  • Alpha-adrenoceptor antagonistic action of amiloride.
  • Catecholaminergic regulation of Na-K-Cl cotransport in pigmented ciliary epithelium: differences between PE and NPE.
  • Effects of higenamine on regulation of ion transport in guinea pig distal colon.
  • Antihypertensive monotherapy and cardiovascular responses to an acoustic startle stimulus.
  • Involvement of both G protein alphas and beta gamma subunits in beta-adrenergic stimulation of vascular L-type Ca(2+) channels.
  • Cardiovascular action of a cardioselective Ca(2+)channel blocker AH-1058 in conscious dogs assessed by telemetry.
  • Cellobiohydrolase 58 (P.c. Cel 7D) is complementary to the homologous CBH I (T.r. Cel 7A) in enantioseparations.
  • Effect of atenolol on symptomatic ventricular arrhythmia without structural heart disease.
  • Relationship between cardiovascular hypertrophy and cardiac baroreflex function in spontaneously hypertensive and stroke-prone rats.
  • Reversal of deteriorated fractal behavior of heart rate variability by beta-blocker therapy in patients with advanced congestive heart failure.
  • Baseline Characteristics and Early Blood Pressure Control in the CONVINCE Trial.
  • Production and characterization of an atenolol-reticulated povodone tablet
  • Use of vancomycin silica stationary phase in packed capillary electrochromatography I. Enantiomer separation of basic compounds.
  • Effect of stimulating non-myelinated vagal axons on atrio-ventricular conduction and left ventricular function in anaesthetized rabbits.
  • Contribution of growth hormone-releasing hormone and somatostatin to decreased growth hormone secretion in elderly men.
  • Partition coefficients of beta-blockers in bile salt/lecithin micelles as a tool to assess the role of mixed micelles in gastrointestinal absorption.
  • The release of the substrate for xanthine oxidase in hypertensive patients was suppressed by angiotensin converting enzyme inhibitors and alpha1-blockers.
  • Quantitative structure-retention and retention-activity relationships of beta-blocking agents by micellar liquid chromatography.
  • Mass spectrometric quantitation of chiral drugs by the kinetic method.
  • Possibilities of using cardioselective beta blocking agents in patients with chronic obstructive bronchopneumopathies
  • Enhancer aided in vitro permeation of atenolol and prazosin hydrochloride through mice skin.
  • Determination of the beta-blocker atenolol in plasma by capillary zone electrophoresis.
  • Ouabain-induced coronary vasoconstriction in cats is not neurally mediated.
  • Coexistence of at least three distinct beta-adrenoceptors in human internal mammary artery.
  • Adrenergic mediation of TNF alpha-stimulated ICAM-1 expression on human brain microvascular endothelial cells.
  • A method for evaluating antianginal drugs in experimental animals: assessment of myocardial ischemia by myocardial pH.
  • Relationship between hydrophobicity and beta-blocking potencies, affinities or dissociation of beta-blockers from beta-adrenoceptors.
  • Interaction of some antiarrhythmic drugs with the heart sarcolemmal Na+-Ca2+ exchange system.
  • Protein kinase A-dependent and -independent effects of isoproterenol in rat isolated mesenteric artery: interactions with levcromakalim.
  • Rx drugs
  • In vivo demonstration of cardiac beta 2-adrenoreceptor sensitization by beta 1-antagonist treatment.
  • Modulation by propranolol of the uptake of ethidium bromide by rat submandibular acinar cells exposed to a P2X(7) agonist or to maitotoxin.
  • Personal formularies. An index of prescribing quality?
  • Effects of six antihypertensive drugs on blood pressure and hypothalamic GABA content in spontaneously hypertensive rats.
  • Determination of metformin in human plasma by high-performance liquid chromatography with spectrophotometric detection.
  • The effect of vasodilators on aspirin-induced antagonism of t-PA thrombolysis.
  • Aldosterone response to antihypertensive treatment.
  • Beta2-adrenoceptor-mediated inhibition of field stimulation induced contractile responses of the smooth muscle of the rat prostate gland.
  • Adrenergic Modulation of Potassium Currents in Isolated Human Atrial Myocytes.
  • beta-Adrenoceptor blockade enhances the anticonvulsant effect of glutamate receptor antagonists against maximal electroshock.
  • Modulation of cardiac activity by tachykinins in the rat substantia nigra.
  • Effect of palmitoyl carnitine isopropyl ester on the actions of BAY K 8644 and norepinephrine in the perfused rat heart.
  • Beta 2-adrenergic receptor signaling acts via NO release to mediate ACh-induced activation of ATP-sensitive K+ current in cat atrial myocytes.
  • Differential effects of heart rate reduction and beta-blockade on left ventricular relaxation during exercise.
  • Anti-atherosclerotic effect of beta-blocker with nitric oxide-releasing action on the severe atherosclerosis.
  • Pharmacological intervention with platelet phospholipase A2.
  • Comparison of the affinity of beta-blockers for two states of the beta 1-adrenoceptor in ferret ventricular myocardium.
  • An improved HPLC-fluorescence stereoselective method for analysis of (+)-S- and (-)-R-sotalol enantiomers in plasma sample.
  • A Study Design for Comparing the Effects of Missing Daily Doses of Antihypertensive Drugs.
  • Screening drugs for metabolic stability using pulsed ultrafiltration mass spectrometry.
  • Enantioselective analysis of atenolol in biologic fluids: comparison of liquid-liquid and solid-phase extraction methods.
  • Combination hypotensive therapy in patients with essential hypertension
  • Cytotoxic interactions of cardioactive cationic amphiphilic compounds in primary rat hepatocytes in culture.
  • Acute effects of alcohol, beta blockade, and their combination on left ventricular function and hemodynamics in normal man.
  • Nylidrin: a potent anti-hypertensive agent in hypertensive rats.
  • Intracellular cAMP increases during the positive inotropism induced by androgens in isolated left atrium of rat.
  • Time-course of the anti-hypertensive action of atenolol: comparison of response to first dose and to maintained oral administration.
  • Isoflurane depresses baroreflex control of heart rate in decerebrate rats.
  • Beta-blockade and exercise capacity in patients with mitral stenosis in sinus rhythm.
  • Capillary isotachophoresis/NMR: extension to trace impurity analysis and improved instrumental coupling.
  • An evaluation of antihypertensive prescribing practices.
  • The influence of antihypertensive agents on circadian rhythms of blood pressure and heart rate in patients with essential hypertension.
  • Effect of atenolol combined with chlortalidone on characteristics of 24-hour blood pressure monitoring
  • Blood lipids and antihypertensive drugs. The Oslo study.
  • Effects of some catecholamines on the cat cardiovascular system: interactions with adrenoceptor antagonists.
  • Differential effects of the angiotensin-converting enzyme inhibitor lisinopril versus the beta-adrenergic receptor blocker atenolol on hemodynamics and left ventricular contractile function in experimental mitral regurgitation.
  • Enantioselective determination of (R)- and (S)-sotalol in human plasma by on-line coupling of a restricted-access material precolumn to a cellobiohydrolase I-based chiral stationary phase.
  • Kinetic spectrophotometric determination of atenolol in dosage forms.
  • Comparison of the effects on airway conductance of a new selective beta-adrenergic blocking drug, atenolol, and propranolol in asthmatic subjects.
  • Rx drugs
  • Effects of underwater massage douche on left ventricular diastolic function in patients with chronic cardiac failure and postinfarction cardiosclerosis
  • Contributions of heart rate and contractility to myocardial oxygen balance during exercise.
  • Simultaneous LC-MS/MS determination of reference pharmaceuticals as a method for the characterization of the Caco-2 cell monolayer absorption properties.
  • Modulation of reflexly evoked vagal bradycardias by central 5-HT1A receptors in anaesthetized rabbits.
  • Partial agonistic activity of labetalol, the arylethanolamine, on beta 3-adrenoceptors in the guinea-pig gastric fundus.
  • Protective effects of adrenoceptor-blocking agents on myocardial injury induced by epinephrine in mice.
  • beta3-Adrenergic regulation of an ion channel in the heart-inhibition of the slow delayed rectifier potassium current I(Ks) in guinea pig ventricular myocytes.
  • Mechanism of antihypertensive effect of atenolol in patients with borderline hypertension during short-term treatment. A comprehensive study.
  • Clinical effectiveness of beta-adrenoblockers and their effects on copulative function in patients with hypertension
  • Cytokine-induced neutrophil chemoattractant 1 (CINC-1) mediates the sympathetic component of inflammatory mechanical hypersensitivitiy in rats.
  • Oxytocinergic regulation of cardiovascular function: studies in oxytocin-deficient mice.
  • A microarray minisequencing system for pharmacogenetic profiling of antihypertensive drug response.
  • Development of a chiral non-aqueous capillary electrophoretic system using the partial filling technique with UV and mass spectrometric detection.
  • Rx drugs
  • Both beta 1- and beta 2-adrenoceptors are involved in mediating phosphatidylcholine secretion in rat type II pneumocyte cultures.
  • Characterization of adrenoceptor involvement in skeletal and cardiac myotoxicity Induced by sympathomimetic agents: toward a new bioassay for beta-blockers.
  • Altered vascular beta adrenoceptor-mediated relaxation in deoxycorticosterone-salt hypertensive rats.
  • The prolonged antihypertensive effect of once daily atenolol: a study of continuous non-invasive arterial blood pressure monitoring.
  • A common beta1-adrenergic receptor polymorphism (Arg389Gly) affects blood pressure response to beta-blockade.
  • Epinephrine promotes pulmonary angiitis: evidence for a beta1-adrenoreceptor-mediated mechanism.
  • Comparison of antihypertensive activity of atenolol and methyldopa at rest and during exercise.
  • Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients.
  • Involvement of noradrenergic system within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats.
  • Comparative pharmacokinetics and pharmacodynamics of propranolol and atenolol in normolipaemic and hyperlipidaemic obese subjects.
  • Direct enantiomeric resolution of (+/-)-atenolol, (+/-)-metoprolol, and (+/-)-propranolol by impregnated TLC using L-aspartic acid as chiral selector.
  • Comparative pharmacokinetics of propranolol and atenolol in primary hyperlipidemia.
  • Disinhibition of rostral raphe pallidus neurons increases cardiac sympathetic nerve activity and heart rate.
  • The interaction between central cholinergic and peripheral beta-adrenergic systems on radial maze performance in rats.
  • Effects of atenolol and diltiazem-SR on quality of life in the hypertensive patients
  • Assessment of cardiac function by echocardiography in conscious and anesthetized mice: importance of the autonomic nervous system and disease state.
  • Quantitation of talinolol and other beta-blockers by capillary electrophoresis for in vitro drug absorption studies.
  • Beta-adrenoceptor activation plays a role in the reverse rate-dependency of effective refractory period lengthening by dofetilide in the guinea-pig atrium, in vitro.
  • pH-dependent bidirectional transport of weakly basic drugs across Caco-2 monolayers: implications for drug-drug interactions.
  • Carvedilol, a new antihypertensive, prevents oxidation of human low density lipoprotein by macrophages and copper.
  • A noninvasive assessment of the gain in baroceptor control of the heart rate in man
  • Antihypertensive effects of atenolol and nitrendipine alone or in combination on three hypertensive models of rats
  • Adrenergic receptors coupled to adenylate cyclase in human cerebromicrovascular endothelium.
  • Evidence for the involvement of beta-adrenergic receptors in conditioned immunomodulation.
  • Cardioselectivity of cetamolol compared with atenolol and nadolol.
  • Heart insufficiency treated with beta-blocking agents. Comparison of responders and non-responders
  • Performance of baboons under a repeated acquisition procedure during chronic oral exposure to atenolol and propranolol.
  • Losartan and atenolol on hypertension induced by adenosine receptor blockade.
  • No effect of enalapril on progression in autosomal dominant polycystic kidney disease.
  • Ion-trapping, microsomal binding, and unbound drug distribution in the hepatic retention of basic drugs.
  • Rx drugs
  • Prophylactic milrinone during OPCAB of posterior vessels: implication in angina patients taking beta-blockers.
  • Rx drugs
  • The A1166C polymorphism of the AT1 receptor gene is associated with collagen type I synthesis and myocardial stiffness in hypertensives.
  • Evidence for cardiac beta 2-adrenoceptors in man.
  • Identification and characterisation of beta-adrenoceptors in guinea-pig skeletal muscle.
  • Recommendations for the management of special populations: racial and ethnic populations.
  • Long-term effects of irbesartan and atenolol on the renin-angiotensin-aldosterone system in human primary hypertension: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA).
  • Long-Term Efficacy of Atenolol for Atrioventricular Reciprocating Tachycardia in Children Less Than 5 Years Old.
  • Ropivacaine combined with various anti-arrhythmic drugs results in mild alterations in myocardial contractility in pigs.
  • Dosage of beta-adrenergic blockers after myocardial infarction.
  • Recommendations for the management of special populations: racial and ethnic populations.
  • Transdermal delivery of timolol and atenolol using electroporation and iontophoresis in combination: a mechanistic approach.
  • Comparison of the anti-hypertensive response to beta-adrenoceptor blocking drugs in intact and adrenal-demedullated spontaneously hypertensive rats.
  • Losartan: in the reduction of stroke risk in patients with hypertension and left ventricular hypertrophy.
  • Influence of atenolol on the relationship between heart rate and QT interval in patients with exercise-induced myocardial ischemia.
  • Receptor binding characteristics and pharmacokinetic properties as a tool for the prediction of clinical effects of beta-blockers.
  • Synergism of atenolol and amlodipine on lowering and stabilizing blood pressure in spontaneously hypertensive rats.
  • Atypical {beta}-Adrenoceptor Subtypes Mediate Relaxations of Rabbit Corpus Cavernosum.
  • Enantioselective chromatography and molecular modeling of novel aryloxyaminopropan-2-ols with the alkyl carbamate function.
  • Regional hemodynamic effects of betaxolol, a new selective beta 1-blocker, and atenolol in conscious spontaneously hypertensive rats.
  • Heart rate--QT relationships during baroreceptor stimulation with diminished autonomic influence on the ventricles. Ventricular autonomic tone and QT interval.
  • The effect of practolol and atenolol on the lysosomal enzyme activity of the ventricular myocardium of rats
  • Atenolol, exaprolol and mast cell membranes.
  • Beta-adrenergic receptors on human tracheal epithelial cells in primary culture.
  • Stereoselective accumulation of the beta-receptor blocking drug atenolol by human platelets.
  • Mechanisms of benefit in the ischemic myocardium due to heart rate reduction.
  • Cardiovascular characterization of the DA2 dopamine receptor agonist quinpirole in rats.
  • Effects of beta-adrenoceptor antagonists on cardiac function in ischemic-reperfused myocardium of the isolated working rabbit heart.
  • Evidence suggesting that the 5-HT2 antagonist ICI 169,369 activates vagal afferents and in addition has a central hypotensive action in anaesthetized rats.
  • Beta 1-adrenoceptors mediate smooth muscle relaxation in mouse isolated trachea.
  • Pharmacokinetics of atenolol enantiomers in humans and rats.
  • Role of vascular angiotensin II released by beta-adrenergic stimulation in rats.
  • Comparison of the effects of cetamolol and atenolol on epinephrine- and isoproterenol-induced hypokalemia in anesthetized dogs.
  • Membrane perturbing activity of beta-adrenoceptor blocking drugs in isolated rat mast cells.
  • Effects of beta 1-adrenergic blockade on glomerular dynamics and angiotensin II response.
  • Beta 2-adrenoceptor-mediated increase in the slow inward calcium current in atrial cells.
  • Membrane stabilizing, anti-oxidative interactions of propranolol and dexpropranolol with neutrophils.
  • Pharmacological characterization of 5-HT receptors in parasympathetic innervation of rat heart.
  • The effect of ethanol on the antiarrhythmic action of atenolol.
  • Modulation of the effects of salbutamol by propranolol and atenolol.
  • Effect of selective blockade of beta 2-adrenergic receptors on portal and systemic hemodynamics in a portal hypertensive rat model.
  • Trends in prescribing of antihypertensive drugs in Australia, 1977-1987.
  • Effects of six beta-blockers on the isolated guinea-pig trachea.
  • Regulation of coronary blood flow by counteraction of coronary vascular alpha and beta adrenergic activation during experimental pliable coronary stenosis.
  • A study on the renal action of beta 1- and beta 2-adrenoceptors in rats
  • Myocardial flow and function after regional beta-blockade in exercising dogs.
  • Analysis of the tachycardiac response to 5-hydroxytryptamine in the spinal guinea-pig.
  • Effects of atenolol and some other beta-adrenoceptor blocking agents on norepinephrine-induced responses in isolated and perfused rat hearts.
  • Theoretical aspects of chiral separation in capillary electrophoresis. III. Application to beta-blockers.
  • The effects of orally administered atenolol on the coronary hemodynamics and prostaglandin metabolism in angina pectoris patients.
  • Time course of regression of left ventricular hypertrophy in hypertensive patients treated with atenolol.
  • Propranolol has direct antithyroid activity: inhibition of iodide transport in cultured thyroid follicles.
  • Platelet function and antithrombin, plasminogen, and fibrinolytic activities in cats with heart disease.
  • Impaired vasodilation during long-term beta 1-selective beta-blockade in hypertensive patients.
  • New cardiovascular acting 2-aryl-2-imidazolinyl-acetic acids. Synthesis and pharmacologic effects
  • The role of antihypertensive pharmacologic treatment in countering adverse pathophysiological profiles: influence on small arteries.
  • Effect of beta-adrenergic antagonists on experimentally induced drinking in female rats.
  • Involvement of cyclic AMP in the positive inotropic effect of OPC-8212, a new cardiotonic agent, on the canine ventricular muscle.
  • Refractoriness of the cyclic AMP response to catecholamines in rat parotid slices in vitro.
  • Chronic beta-adrenoceptor antagonist treatment modulates human cardiac and vascular beta-adrenoceptor density in a subtype-selective fashion.
  • Gallopamil and chlorthalidone versus atenolol and chlorthalidone in the treatment of obstructive hypertrophic cardiomyopathy in patients with arterial hypertension: polycardiographic evaluation of the systolic and diastolic function of the left ventricle
  • A simple method to determine the ratio of cardiac to vascular beta-receptor blockade in the rat in vivo.
  • Factors relating to the beta blocker withdrawal syndrome.
  • Binding of beta-adrenoceptor blocking drugs to human serum albumin, to alpha 1-acid glycoprotein and to human serum.
  • Acute effects of metoprolol on blood pressure and heart rate. Value of the nitroglycerin test
  • Possible significance of the pharmacological differentiation of beta-blocking agents in hemodynamic effects in essential hypertension.
  • Central haemodynamic effects of beta blockers in hypertension. A comparison between atenolol, metoprolol, timolol, penbutolol, alprenolol pindolol and bunitrolol.
  • Haemodynamic response to antihypertensive treatment with atenolol in patients with hypertension (author's transl
  • Characterization of putative beta-adrenoceptors in the myometrium of the pregnant ewe: correlation between the binding of 3H dihydroalprenolol and the inhibition of myometrial contractility in vitro.
  • Enhancement of physiological finger tremor by intravenous isoprenaline infusions in man: evaluation of its role in the assessment of beta-adrenoceptor antagonists.
  • Beta-receptor stimulation by adrenaline elevates plasma noradrenaline and enhances the pressor responses to cold exposure and isometric exercise.
  • Comparison of the positive chronotropic response to 5-hydroxytryptamine with beta-adrenoceptor agonists on the guinea pig atria in vitro.
  • Studies on the mechanisms by which clenbuterol, a beta-adrenoceptor agonist, enhances 5-HT-mediated behaviour and increases metabolism of 5-HT in the brain of the rat.
  • Comparative studies of (--)-, (+/-)-propranolol, atenolol, guanethidine, bretylium and tetracaine on adrenergic transmission.
  • Enhancement of prostaglandin output during activation of beta-1 adrenoceptors in the isolated rabbit heart.
  • Mode and mechanism of action of 3,4-dihydro-6-4-(3,4-dimethoxybenzoyl)-1-piperazinyl-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, on the dog heart.
  • Atenolol pharmacokinetics in patients on continuous ambulatory peritoneal dialysis.
  • Indobufen interacts with the sulphonylurea, glipizide, but not with the beta-adrenergic receptor antagonists, propranolol and atenolol.
  • Long-term hypotensive effect of atenolol 4% eyedrops.
  • Pharmacokinetic studies with atenolol in the dog.
  • Pressure and humoral changes induced by atenolol and hydrochlorothiazide + amiloride, alone and in free combination. A comparative between-patient study.
  • Effect of atenolol on plasma HDL cholesterol subfractions.
  • Clinical pharmacology of adrenergic-adrenoreceptor-blocking drugs.
  • Effect of pretreatment with atenolol and propranolol on sympatho-adrenal and cardiovascular responses to acute insulin-induced hypoglycaemia in the hypertensive patient
  • Atenolol in the treatment of essential hypertension during pregnancy.
  • Effects of adrenolytic drugs on the antihypertensive action of beta-blocking agents in the acute neurogenic hypertensive dog.
  • Pharmacokinetics of atenolol in patients with terminal renal failure and influence of haemodialysis.
  • Pharmacokinetics of atenolol in relation to renal function.
  • Is asparagine-linked protein glycosylation an obligatory requirement for angiogenesis?
  • Effect of arotinolol on the incomplete tetanic contractions of the cat soleus muscle--relation to its anti-tremorgenic action
  • Isoproterenol, denopamine, and atenolol-induced alterations in beta-adrenergic receptor-adenylate cyclase system of rat myocardium
  • Effect of buffer solution pH on the elution and separation of beta-blockers by micellar electrokinetic capillary chromatography.
  • Toxicity of beta-blockers in a rat whole embryo culture: concentration-response relationships and tissue concentrations.
  • Electron-capture-gas chromatographic determination of atenolol in plasma and urine, using a simplified procedure with improved selectivity.
  • Propranolol inhibits cyclic AMP accumulation and amylase secretion in parotid acinar cells stimulated by isobutylmethylxanthine and forskolin.
  • Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 3rd communication: antihypertensive effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno2, 3-b pyridine-5-carboxylate in hypertensive rats and dogs.
  • Effects of beta 1- and beta 2-adrenoceptor agonists applied into the hypothalamic paraventricular nuclei of spontaneously hypertensive rats on urine production.
  • Comparison of cumulative and non-cumulative administration of vasoactive agents in arterial smooth muscle responses in vitro.
  • The affinity of betaxolol, a beta 1-adrenoceptor-selective blocking agent, for beta-adrenoceptors in the bovine trachea and heart.
  • Comparison of early and late start of antihypertensive agents and baroreceptor reflexes.
  • Application of intracerebral microdialysis to study regional distribution kinetics of drugs in rat brain.
  • Some pharmacological studies on the effects of Cerastes vipera (Sahara sand viper) snake venom.
  • Pharmacokinetics of atenolol in clinically normal cats.
  • Different effects of calcium antagonists, nitrates, and beta-blockers on platelet function. Possible importance for the treatment of unstable angina.
  • High-performance liquid chromatographic determination of sotalol in biological fluids.
  • Chronic beta 1-adrenoceptor antagonist treatment sensitizes beta 2-adrenoceptors, but desensitizes M2-muscarinic receptors in the human right atrium.
  • Influence of atenolol and/or metformin on glutathione and magnesium levels in diabetic rats.
  • Alveolar liquid clearance in the anesthetized ventilated guinea pig.
  • Influence of nitric oxide on vascular, metabolic, and contractile responses to dobutamine in in situ canine hearts.
  • Optimization of mobile phase in the separation of beta-blockers by HPLC.
  • Influences of age on the positive inotropic effect mediated by alpha- and beta-adrenoceptors in rat ventricular strips.
  • Characterization of postjunctional adrenoceptor subtypes in isolated rat myocardial cells in culture.
  • Study of beta-adrenoceptors and beta-adrenergic responsiveness in cultured "preneoplastic-like" and neoplastic rat hepatocytes.
  • Autonomic blockade does not prevent learned heart rate attenuation during exercise.
  • Memory-enhancing effects of posttraining naloxone: involvement of beta-noradrenergic influences in the amygdaloid complex.
  • Anaesthesia: the role of adrenergic mechanisms.
  • Nifedipine and platelets in preeclampsia.
  • Effect of aging on atenolol pharmacokinetics and pharmacodynamics.
  • Multicentre general practitioner assessment of 'Tenormin' and methyldopa.
  • Comparative effects of prazosin and atenolol on plasma lipids in hypertensive patients.
  • Do beta blockers prevent pressor responses to mental stress and physical exercise?
  • Predicting the blood pressure response to atenolol.
  • Variability in the preventive action of the B-blockers on genetic hypertension in the rat.
  • The myocardial lesions produced by the potassium channel opener aprikalim in monkeys and rats are prevented by blockade of cardiac beta-adrenoceptors.
  • Interaction between prolactin and catecholamines on hypothalamic GnRH release in vitro.
  • The unit impulse response procedure for the pharmacokinetic evaluation of drug entry into the central nervous system.
  • Exercise training during chronic beta blockade in cardiovascular disease.
  • Effects of intracoronary propranolol on coronary blood flow and regional myocardial function in dogs.
  • Characterization of propranolol-induced relaxation of coronary artery.
  • The in vitro effects of propranolol and atenolol on neutrophil motility and post-phagocytic metabolic activity.
  • Spectral analysis of blood pressure and heart rate in conscious rats: effects of autonomic blockers.
  • Antihypertensives and the prevention of development of genetic hypertension in the hypertensive SHR rat
  • Suppression of ventricular premature contractions continues after the washout of antiarrhythmic drugs.
  • Ocular absorption of Pz-peptide and its effect on the ocular and systemic pharmacokinetics of topically applied drugs in the rabbit.
  • Tissue levels of several radiolabelled beta-adrenoceptor antagonists after intravenous administration in rats.
  • Pyramidal control of heart rate and arterial pressure in cats.
  • Characterization of the receptor mediating the antianaphylactic effects of beta-adrenoceptor agonists in human lung tissue in vitro.
  • The metabolic and circulatory response to beta-blockade in hypertensive men is correlated to muscle capillary density.
  • Beta-adrenergic receptor-mediated phospholipase C activation independent of cAMP formation in turkey erythrocyte membranes.
  • A study of dopamine receptors in guinea-pig renal tissue.
  • Value of heart rate recordings in selecting the initial treatment of hypertension
  • Effect of beta-adrenergic receptor blockade on atrial natriuretic peptide in essential hypertension.
  • Protection by beta-blocking agents against free radical-mediated sarcolemmal lipid peroxidation.
  • Effects of atenolol on regional myocardial blood flow and ST segment elevation in the canine myocardium.
  • Pressor response to beta 1- and beta 2-blockers in conscious rats treated with phentolamine.
  • Dosing rate-dependent relationship between propranolol plasma concentration and beta-blockade.
  • Cardiac noradrenaline release accelerates adenosine formation in the ischemic rat heart: role of neuronal noradrenaline carrier and adrenergic receptors.
  • Mechanism and pressor relevance of the short-term cardiovascular and renin excitatory actions of the selective A2A-adenosine receptor agonists.
  • Hypotensive effect of clonidine is not mediated by enhanced baroreflex gain in rats.
  • Endothelial renin-angiotensin pathway. Adrenergic regulation of angiotensin secretion.
  • The role of cardiac beta-1 receptors in the hemodynamic response to a beta-2 agonist.
  • Left stellate stimulation: regional myocardial flows and ischemic injury in dogs.
  • Isoproterenol inhibits residual fast channel via stimulation of beta-adrenoceptors in guinea-pig ventricular muscle.
  • Nifedipine as a second line antihypertensive drug in pregnancy.
  • Behavioral and cardiac responses to mild stress in young and aged rats: effects of amphetamine and vasopressin.
  • Amylase secretion in response to activation of different autonomic receptors in the rabbit parotid gland.
  • Liquid chromatographic retention of beta-adrenoceptor antagonists: an index of lipid solubility.
  • Fundamental studies in reversed-phase liquid-solid extraction of basic drugs; II: Hydrogen bonding effects.
  • Subtypes of beta adrenergic receptors mediating pigment dispersion in chromatophores of the medaka, Oryzias latipes.
  • Coronary effects of a combined beta adrenoceptor blocking and calcium antagonist therapy in running dogs.
  • Loss of 125I-pindolol binding to beta-adrenoceptors on rat nodose ganglion after chronic isoprenaline treatment.
  • Beta adrenoceptors of human red blood cells, determination of their subtypes.
  • Effect of norepinephrine on rat basilar artery in vivo.
  • The importance of choice of agonist in studies designed to predict beta 2 : beta 1 adrenoceptor selectivity of antagonists from pA2 values on guinea-pig trachea and atria.
  • Long-term efficacy and safety of beta-adrenergic receptor antagonists for supraventricular tachycardia.
  • Cardiotoxic effects of salmeterol in comparison with salbutamol on the isolated perfused Langendorff-heart of the rat.
  • 201-thallium stress scintigram in patients with coronary artery disease after administration of the cardioselective betablocker atenolol
  • Parotid degeneration secretion of amylase in vitro in the rat following sympathectomy.
  • Are the pA2 values of selective beta-adrenoceptor antagonists valid when obtained on guinea-pig tracheal preparations contracted with carbachol?
  • Adrenergic hypersensitivity after beta-blocker withdrawal.
  • Beta-adrenoceptor mediated secretion of active and inactive renin in conscious sheep.
  • Neural and non-neural components of the developing hypertension in genetically hypertensive rats.
  • Comparative effects of seven beta adrenolytic agents on blood pressure after injection into the posterior hypothalamus of rats. The frequency heart and the plasma renin activity
  • Effect of beta-adrenoceptor antagonists on prevalence of peripheral vascular symptoms in hypertensive patients.
  • Metabolic actions of a single atenolol and metoprolol dose.
  • The importance of lipid solubility and receptor selectivity of beta-adrenoceptor blocking drugs for the occurrence of symptoms and side-effects in out-patients.
  • Determination of nadolol in serum by high-performance liquid chromatography with fluorimetric detection.
  • Inhibitors of prostaglandin synthesis reverse the effects of chronic beta-receptor blockade to attenuate adrenergic neurovascular transmission in dogs.
  • Changes in cardiac glycogen synthase and phosphorylase activities following stimulation of beta-adrenergic receptors in rats.
  • Conformational structure of some beta 1-blockers, their partitioning in lipid and the role of parasubstituents.
  • Fluorimetric and solubility studies of nadolol and atenolol in SDS micelles.
  • Stimulation of calcium pump activity in heart sarcolemma by timolol.
  • Beta-blocker brain concentrations in man.
  • Beta-adrenergic agonists stimulate the oxidative pentose phosphate pathway in the rat heart.
  • Effects of electrical stimulation of the sympathetic nerve on the levels of beta-adrenergic and cholinergic muscarinic receptors and cyclic nucleotides in rat salivary glands.
  • Beta-adrenoceptor stimulation enhances transmitter output from the rat phrenic nerve.
  • Beta 2-adrenergic stimulation of androgen production by cultured mouse testicular interstitial cells.
  • Alpha 1-adrenergic stimulation of phospholipase C activity in purified cardiac sarcolemmal membranes.
  • Behavioral and biochemical studies in rats following prenatal treatment with beta-adrenoceptor antagonists.
  • Calcium levels in rat submandibular gland and saliva after sympathetic nerve stimulation in the presence of alpha, beta 1 and beta 2-adrenergic antagonists.
  • Effects of propranolol and atenolol on the rat kidney
  • Response to cardiac sympathetic activation in transgenic mice overexpressing beta 2-adrenergic receptor.
  • Effects of alterations in sympathetic nervous activity on the severity of reperfusion-induced arrhythmias in anaesthetised rats.
  • Formulation influence on conjunctival penetration of four beta blockers in the pigmented rabbit: a comparison with corneal penetration.
  • Response of neurocardiac syncope to beta-blocker therapy: interaction between age and parasympathetic tone.
  • Soft drugs. XX. Design, synthesis, and evaluation of ultra-short acting beta-blockers.
  • The effect of atenolol on the growth hormone response to growth hormone-releasing hormone in obese children.
  • The effect of triple drug therapy on renal function in patients with essential hypertension.
  • Cardiovascular effects of the benzodiazepine receptor partial inverse agonist FG 7142 in rats.
  • The excitatory effects of the amygdala on hypothalamo-pituitary-adrenocortical responses are mediated by hypothalamic norepinephrine, serotonin, and CRF-41.
  • Withdrawal of long-term therapy with atenolol in hypertensive patients.
  • Angina pectoris--drug therapy and costs in a medical outpatient clinic in Switzerland
  • Potentiation of thermoregulatory responses to isoproterenol by beta-adrenergic antagonists.
  • Exacerbation of reperfusion arrhythmias by alpha 1 adrenergic stimulation: a potential role for receptor mediated activation of sarcolemmal sodium-hydrogen exchange.
  • Exercise increases plasma concentrations of (R)- and (S)-propranolol.
  • The role of beta1 and beta2 adrenoceptors in isoproterenol-induced drinking.
  • Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs
  • Cardiac receptors modulate the renal sympathetic response to dynamic exercise in rabbits.
  • Beta-adrenergic stimulation and abdominal subcutaneous fat blood flow in lean, obese, and reduced-obese subjects.
  • On the relationship between the inhibition of thrombin stimulated aggregation and thromboxane formation in isolated platelets treated with beta-adrenoceptor blocking drugs.
  • A 1-year follow-up study on the effect of atenolol on serum beta 2-microglobulin level in hypertensive diabetic patients.
  • The costo-uterine muscle of the rat contains a homogeneous population of beta-adrenoceptors.
  • Beta blockers inhibit fetal thromboxane A2 production in vitro.
  • Temperature dependence of 3Hdihydroalprenolol binding in rat myocardium.
  • Effects of antihypertensive agents on baroreceptor function in early hypertensive rats.
  • Autonomic nervous system control of heart rate during baroreceptor activation in conscious and anesthetized rats.
  • The combined use of DSC and TGA for the thermal analysis of atenolol tablets.
  • Role of 5-HT1A receptors in the forced swimming wheel test in reserpine-treated mice.
  • A comparison of Chinese traditional and Western medical approaches for the treatment